If you want to distinguish your goods, services or both from those of another company, you may need a trademark or trade name. Find out what they are, what their registration procedure is and what it involves.
Information on the deadlines for filing applications for transformation of European Union trademarks into Spanish national trademarks. See more
If you have a new device, product or procedure that solves a technical problem or has a practical advantage, there are different ways to protect it in Spain and other countries. Find out how.
Does your innovation lie in the aesthetics, ornamentation or appearance of your product? Protect it through industrial design. Find out what rights registration confers and how to proceed.
Geographical indications protect the name of a product that has a specific geographical origin and owes its qualities, characteristics or reputation to its particular origin. Find out what they are, how the registration process works and what benefits they provide.
Patents published worldwide are a valuable source of scientific, technical and commercial information.
El Bono 3 del Fondo para PYMEs 2025, que cubre la elaboración de Informes Tecnológicos de Patentes (ITP) y Búsquedas Retrospectivas se cerrará el lunes 10 de febrero de 2025 al cierre de la jornada laboral. Próximamente se informará sobre su reapertura. Puede consultar más información aquí.
If you are an entrepreneur or a company and you want to boost and improve the profitability of your business by adequately protecting the intangible assets of your organisation, in this space you will find what you need.
302
results.
Updated on
24/04/2026 [07:12:00]
Absstract of: CN224130476U
本实用新型属于骨科技术领域，具体的说是一种骨科导板制作装置，包括机体和保护装置，机体的上表面滑动连接有加工器，机体的上表面滑动连接有垫板，机体的表面固定连接有控制板；机体的表面设有保护装置，保护装置包括支撑板和两个护罩，支撑板的上表面和机体底端固定连接，支撑板的内壁螺纹连接有两个螺纹杆，两个护罩位于机体的表面，垫板的表面设有清理装置，清理装置包括两个放置板，两个放置板的侧壁分别和垫板两侧固定连接，两个放置板的内壁滑动连接有滑架，滑架的底端固定连接有刮刀；通过设置护罩能够对整个设备进行保护，同时减少设备沾染灰尘的情况，而支撑轮能够在一定程度上支撑护罩。
Absstract of: CN121872768A
本发明公开了一种3D打印牙冠的陶瓷浆料及其制备方法，包括如下组分：光敏树脂、稀释剂、分散剂、消泡剂、光引发剂、陶瓷粉体；制备的时候包括如下步骤，S1,首先调节混合环境，将混合温度调整30‑40℃；将光敏树脂、光引发剂、稀释剂高速避光搅拌均匀，混合得到光敏树脂体系；S3，将陶瓷粉体、分散剂、助剂加入上述光敏树脂体系中，进行分散得到浆料，在成型软件控制下完成牙科种植体素坯的打印；S8，将素坯进行干燥、脱脂、高温烧结后得到牙冠种植体；本发明所涉及的陶瓷浆料进行3D打印成型的牙冠陶瓷生坯具有很高硬度，而且生坯精度高、打印成功率高。通过脱脂烧结热反应对其内部晶粒尺寸进行重构，经过脱脂烧结后的陶瓷牙冠能够与牙模准确佩戴。
Absstract of: CN121868011A
本申请提供一种义肢接受腔、义肢及其制造方法，包括：外壳，外壳用于连接义肢体；缓冲层结构，缓冲层结构环绕设置在外壳内，缓冲层结构具有负泊松比特性；柔性内衬，柔性内衬设置在缓冲层结构的内腔内，并形成一侧敞开的接受空腔，接受空腔用于连接用户的残肢；外壳、缓冲层结构以及柔性内衬通过双头3D打印生成，其中在双头3D打印过程中通过第一挤出头和第二挤出头进行同步打印，第一挤出头以柔性材料打印出柔性内衬以及缓冲层结构，第二挤出头以硬质材料打印外壳。解决了现有技术中的义肢接受腔生产工序多、浪费劳动力资源的问题。
Absstract of: CN121872675A
本发明提供了一种用于3D打印的牙科修复体材料、牙科修复体及制备方法。该牙科修复体材料以质量分数计包括以下修复体原料：1，6‑己二醇二丙烯酸酯8％～16％，乙氧基化三羟甲基丙烷三丙烯酸酯1％～5％，聚乙二醇4009％～13％，二苯基(2，4，6‑三甲基苯甲酰基)氧化膦0.2％～1％，分散剂1％～5％，玻璃粉60％～85％。其中，玻璃粉的组成以质量分数计包括：SiO2 50％～80％，Li2O 10％～20％，K2O 0.5％～10％，Al2O3 0.5％～15％，成核剂0.2％～10％。所述成核剂为P2O5和/或TiO2。该牙科修复体材料制备的牙科修复体力学强度能超过200MPa。
Absstract of: CN121868005A
本发明提供了一种3D打印复合材料支架及其制备方法，本发明结合3D打印技术、铸造、注塑、渗流法制备3D打印复合材料支架。本发明结合3D打印材料的多孔结构与其他材料，制备出了一种结合力学性能极佳的支架，该方法解决了目前3D打印无法有效直接制备复合材料支架的问题，解决了钛合金、钽合金等3D打印材料多与其他材料结合不牢固的技术问题。该制备方法包括以下步骤：设计多孔结构三维模型，并导出打印机识别格式数据；3D打印得到多孔结构；设计和/或选择其他材料及制备模具；将3D打印得到的多孔结构相对固定于模具中；向模具内灌注其他材料，该材料会流进3D打印多孔结构的孔隙内部；固化和/或硬化得到3D打印复合材料支架。本发明的3D打印复合材料支架可以用于骨科植入物中，该3D打印复合材料支架具备结构牢固、不易破坏，骨长入效果好的优点，可应用于承重部位的大段骨缺损，在起到力学支撑的基础上促进骨组织再生，达到修复大段骨缺损的疗效。
Absstract of: CN121868006A
本申请提供了复层结构颅骨修复支架及其制备方法和制备工艺优化方法，涉及颅骨修复支架技术领域，包括进行CT和核磁共振扫描获得缺损颅骨组织三维结构模型；构建复层结构颅骨修复支架结构基准模型，包括外部金属支撑层、内部生物陶瓷降解再生层和中间过渡界面层；拓扑优化结合挤出模拟、打印模拟和烧结模拟进行联合优化；采用挤出3D打印技术配置3D打印浆料进行打印获得复层结构颅骨修复支架打印体；真空干燥、真空烧结、冷却后获得复层结构颅骨修复支架。本申请结合金属、陶瓷两种材料，外层金属框架提供手术所需初始强度、刚性及可靠的固定能力；内层多孔的可降解生物陶瓷，创造利于新骨生成的微环境，最终实现支架的生物降解与骨组织的原位再生。
Absstract of: WO2026076477A1
The invention relates to a sliding element (1), in particular for medical components for use in implantology, comprising a substrate (3) and a biomaterial (2) applied to the substrate (3), which biomaterial provides a sliding layer (1a) on its side facing away from the substrate (3), wherein the substrate (3) has multiple cavities (7) on a connection surface (4) facing the biomaterial (2), wherein the cavities (7) are open in the direction of the sliding layer (1a) and at least 50% of the cavities (7) have an undercut (7a) in the direction of the interior of the substrate (3), wherein the substrate (3), in a first profile depth (a) of at least 0.6 μm, has a round-ridged roughness profile with an areal roughness characteristic Sa of less than 0.05 μm, wherein the substrate (3) has the multiple cavities (7) between the first profile depth (a) and a second profile depth (b), and wherein the second profile depth (b) measures at least 200 μm, preferably at least 350 μm.
Absstract of: US20260104835A1
0000 A continuous glucose monitor for wirelessly transmitting data relating to glucose value to a plurality of displays is disclosed, as well as systems and methods for limiting the number of display devices that can connect to a continuous glucose transmitter. In addition, security, including hashing techniques and a changing application key, can be used to provide secure communications between the continuous glucose transmitter and the displays. Also provided is a continuous glucose monitor and techniques for authenticating multiple displays, providing secure data transmissions to multiple displays, and coordinating the interaction of commands and data updates between multiple displays.
Absstract of: US20260106031A1
Provided is a computer-implemented device for generating a type-Il (T2DM) diabetic status prediction, including: a memory comprising a diabetic status prediction model; and a processor in communication with the memory, the processor configured to: receive a voice sample from the subject; extract at least one voice biomarker feature value from the voice sample for at least one predetermined voice biomarker feature; determine the type-II (T2DM) diabetic status prediction for the subject based on the at least one voice biomarker feature value and the diabetic status prediction model; and output, to an output device, the type-II (T2DM) diabetic status prediction for the subject or an output based on the diabetic status prediction.
Absstract of: US20260102090A1
0000 A method for calibrating and/or verifying an implantable detecting device, an implantable detecting device, an apparatus, and an electronic device are provided. The method includes: outputting a square wave signal to an implantable detecting device that has been implanted into a subject, where the implantable detecting device is configured to detect a concentration of an analyte in the subject, and a potential of the square wave signal increases incrementally over time; receiving a first current signal produced by the implantable detecting device in response to the square wave signal; generating a calibration curve based on a correspondence between the first current signal and the square wave signal; and performing calibration and/or functional verification on the implantable detecting device based on the calibration curve.
Absstract of: US20260102124A1
0000 Certain aspects of the present disclosure relate to methods and systems for providing decision support around glucose management for patients with diabetes. Time-varying inputs including blood glucose, meal intake information, and amount of infused insulin are processed using a machine learning model to obtain predicted glucose levels for a plurality of prediction horizons and uncertainties for the predictions. A confidence interval is generated for each prediction and the confidence intervals are compared to hypo- and hyperglycemic thresholds. If a confidence interval is entirely below or entirely above the hypo- and hyperglycemic thresholds, respectively, then a decision support output is provided.
Absstract of: US20260102187A1
0000 Aspects of the disclosure relate to an adjustable implant configured to be implanted into a patient that includes an adjustable portion moveable relative to a housing. The adjustable implant may include various smart components for enhancing operation of the implant. Smart components may include a controller for managing operations and a transducer for communicating ultrasound data with an external interface device. Additional smart components may include a load cell within the housing for measuring an imparted load; a sensor for measuring angular position of the adjustable portion; a dual sensor arrangement for measuring imparted forces; a reed switch; a half piezo transducer; and an energy harvester.
Absstract of: US20260103781A1
0000 A metal alloy that includes an enhancement coating material. The metal alloy includes rhenium and one or more additives. The enhancement coating is at least partially applied to the metal alloy by a physical vapor deposition (PVD) process, a chemical vapor deposition (CVD) process, an atomic layer deposition (ALD) process, a plasma-enhanced chemical vapor deposition (PE-CVD) process, ion implantation, direct energy deposition (DED), and/or thermal spray techniques like plasma arc spraying, flame spraying, high velocity oxy fuel spraying (HVOF). The enhancement coating is formed of a) 35-95 wt. % zirconium and wherein said enhancement coating includes ZrN, ZrNC, ZrOC or a combination of ZrN and ZrO2, b) 20-85 wt. % titanium and one or more of carbon, nitrogen, oxygen, rhenium, and silicon, c) 40-85 wt. % chromium and one or more of carbon, nitrogen, oxygen, rhenium, and silicon, or d) at least 60 wt. % carbon.
Absstract of: US20260102139A1
0000 Circuitless heart rhythm determination can include capturing a video clip of one or more image frames of a target organ through an ultrasound imaging device and submitting the frames to a classifier that has been trained with an annotated set of images, each of a corresponding heart muscle captured at a specified phase of a heart rhythm with a ground truth indication of the specified phase of the heart rhythm drawn from a separately recorded cycle graph of an electrical signal measured over time for the corresponding heart muscle. In response to the submission, a classification can be received of different portions of the submitted frames according to corresponding phases of the heart rhythm. Finally, a contemporaneous phase of the heart rhythm can be determined in the device without sensing electrical signals by way of a closed-loop sensor circuit affixed proximately to the target heart muscle.
Absstract of: US20260102576A1
A respiratory therapy system for providing continuous positive air pressure (CPAP) to a patient may include a flow generator for generating a supply of breathable gas, a sensor to measure a physical quantity while the breathable gas is supplied, and a computing device. The computing device may be configured to: receive sensor data that is based on measured physical property of the supply of breathable gas; control the flow generator to adjust a property of the supply of breathable gas; display a question and a plurality of selectable responses; receive a first input selecting one of the selectable responses; and display a coaching response corresponding to the selected response.
Absstract of: US20260102223A1
A dental appliance for a patient includes a body including a first surface and a second surface opposite to the first surface. The second surface defines a channel for receiving a plurality of teeth of the patient. The dental appliance further includes an arrangement of a plurality of features disposed on the first surface of the body. Each of the plurality of features includes a protrusion extending from the first surface opposite to the second surface; a depression extending partially from the first surface wards the second surface; or a through-hole extending from the first surface to the second surface. The arrangement of the plurality of features encodes a feature data representative of a dental appliance information of the dental appliance or a patient information of the patient.
Absstract of: US20260102066A1
A method and system for non-invasively determining continuous total hemoglobin data is provided. The method includes a) using a near infra-red spectrophotometric (NIRS) sensing device on a continuous basis to sense a subject's tissue, the sensing producing NIRS signals; and b) determining continuous total hemoglobin (THb) using the produced NIRS signals.
Absstract of: US20260105916A1
0000 ice control of medical devices in a healthcare facility are disclosed herein. The systems employ continuous speech processing software, voice recognition software, natural language processing software, and other software to permit voice control of the medical devices. Systems are also provided for distinguishing which medical device from among multiple medical devices in a patient room is the particular medical device to be controlled by voice input from a caregiver or a patient.
Absstract of: US20260102624A1
0000 Systems and methods for controlling a mobile defibrillator (AED) unit are provided.
Absstract of: US20260102067A1
0000 An apparatus for monitoring a person's health conditions. The apparatus has one or more biometric sensors for periodically measuring the person's biometric data, one or more activity sensors for periodically measuring the person's activities, and a circuit functionally coupled to the one or more biometric sensors and the one or more activity sensors, the circuit having an artificial intelligence (AI) engine configured for using a trained AI model for analyzing the person's health condition based on the measurement data collected from the one or more biometric sensors and the one or more activity sensors.
Absstract of: US20260102288A1
A system for creating a tissue interface. The system includes a scanner, at least one processor, and a memory. The scanner is configured to scan a tissue site and generate a signal corresponding to a topography of the tissue site. The at least one processor is configured to receive the signal corresponding to the topography of the tissue site and to receive user input at a user interface identifying a therapy to be applied at the tissue site. The memory is coupled to the at least one processor and is configured to store instructions that when executed by the at least one processor in response to receiving the signal corresponding to the topography of the tissue site cause the system to transform the signal corresponding to the topography of the tissue site into a model site surface and generate a model tissue interface.
Absstract of: US20260102258A1
0000 A novel 3D (three-dimensional) printing self-stabilizing cervical interbody fusion cage is provided, including a fusion cage body, circular-arc notches arranged at four corners of a front side surface of the fusion cage body, and threaded openings are formed in interiors of the circular arc notches and screws are correspondingly mounted in the threaded openings. An inner wall of the fusion cage body is of a circular arc structure, and a reserved circular opening is formed in the middle position of the front side surface. Each of the circular arc notches is positioned to form an angle of 45° with a horizontal plane of each of the four corners of the fusion cage body. Screw are self-tapping screws with threads, and the threads of the screws are in fit with threads of the inner walls of the circular arc notches.
Absstract of: US20260102509A1
A nanoparticle compound comprising buckminsterfullerene C60 bonded to ester functional groups of pyruvic, citric, and hyaluronic acids, with oxygen-bridged components selected from vanadium, gallium, and bismuth is provided. At least one component enables quantum-mechanical spin-wave activation. Ultrasonic irradiation activates the compound, inducing electrical induction for tissue healing and cell growth. The compound integrates with native and 3D-printed tissues, enhancing their properties through interpenetrating networks. It exhibits anti-inflammatory, antioxidant, and antibacterial effects, reinforces connective tissue, and modulates stem cell growth. The compound treats arthritis, enhances gut health and barrier function, supports bone health, improves voice quality, counters cancer cell proliferation, and mitigates osteoporosis. The gallium component creates an alkaline environment for calcium deposition, while vanadium enhances chondrogenic differentiation. Administration methods include topical application, oral ingestion, injection, and infusion through bandages or sutures. The compound serves as an adjuvant for analgesics, enhancing their delivery and efficacy.
Absstract of: WO2026080718A1
The disclosed concept includes the preparation and use of biocompatible bioinks, as well as techniques and methods therein for bioprinting, preparing and 3D printing primary cells and patient-specific cells and forming functional soft tissue in a three-dimensional construct form that incorporates the cells and mimics native tissues. The biocompatible bioinks include alginate, methylcellulose, and primary or iPSC-derived cells in the form of single cells or aggregates. The bioprinted 3D construct includes one or more of the iPSC organoids, human islets, as well as TEPCs.
Nº publicación: WO2026078545A1 16/04/2026
Applicant:
NEW YORK UNIV IN ABU DHABI CORPORATION [AE]
Absstract of: WO2026078545A1
Synthetic corneal stroma are created though a bioprinting process. The bioprinting process utilizes Digital Light Processing (DLP) in the formation of the corneal stroma. A hydrogel is formed to serve as the basis for the DLP printing. The DLP printing process provides control exposure of the hydrogel to UV light. The bioprinting through the DLP printing process forms a synthetic corneal stroma.
BOPI
Electronic site
